Literature DB >> 19424770

Congenital isolated hemifacial hyperplasia.

Peter P Urban, Roland Bruening, Bruening Roland.   

Abstract

We report on a 14-year-old boy with congenital isolated hemifacial hyperplasia. Hemifacial hypertrophy most likely represents a minor form of congenital hemihypertrophy. MRI of the soft tissue is particularly suitable to support the diagnosis and reveal associated bony asymmetries.

Entities:  

Mesh:

Year:  2009        PMID: 19424770     DOI: 10.1007/s00415-009-5148-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  9 in total

1.  Hemifacial hypertrophy. Review of the literature and addition of four cases.

Authors:  N H ROWE
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1962-05

2.  A truly unusual overgrowth syndrome: an alternative diagnosis to Klippel-Trénaunay-Weber syndrome.

Authors:  Ahmad I Alomari
Journal:  Intern Med       Date:  2009-03-16       Impact factor: 1.271

3.  Hemifacial myohyperplasia: description of a new syndrome.

Authors:  S Lee; R Sze; C Murakami; J Gruss; M Cunningham
Journal:  Am J Med Genet       Date:  2001-11-01

4.  Hemifacial hypertrophy. Report of two cases.

Authors:  J N Khanna; N N Andrade
Journal:  Int J Oral Maxillofac Surg       Date:  1989-10       Impact factor: 2.789

5.  Isolated hemifacial hypertrophy: a case with upper airway obstruction and sensorineural hearing loss.

Authors:  M F Oktay; I Topcu; A McKinney; V Turunz; O Aras
Journal:  J Laryngol Otol       Date:  2006-05-15       Impact factor: 1.469

6.  15q overgrowth syndrome: a newly recognized phenotype associated with overgrowth, learning difficulties, characteristic facial appearance, renal anomalies and increased dosage of distal chromosome 15q.

Authors:  Katrina Tatton-Brown; Daniela T Pilz; Karen Helene Orstavik; Michael Patton; John C K Barber; Morag N Collinson; Vivienne K Maloney; Shuwen Huang; John A Crolla; Karen Marks; Eli Ormerod; Peter Thompson; Zafar Nawaz; Christa Lese-Martin; Susan Tomkins; Paula Waits; Nazneen Rahman; Meriel McEntagart
Journal:  Am J Med Genet A       Date:  2009-02       Impact factor: 2.802

7.  Increased proliferative activity of osteoblasts in congenital hemifacial hypertrophy.

Authors:  H Yoshimoto; H Yano; K Kobayashi; A Hirano; K Motomura; A Ohtsuru; S Yamashita; T Fujii
Journal:  Plast Reconstr Surg       Date:  1998-10       Impact factor: 4.730

8.  Comparison between true and partial hemifacial hypertrophy.

Authors:  Mohammed N Islam; Indraneel Bhattacharyya; Junu Ojha; Karen Bober; Donald M Cohen; James G Green
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2007-04-20

9.  Mutations in RNF135, a gene within the NF1 microdeletion region, cause phenotypic abnormalities including overgrowth.

Authors:  Jenny Douglas; Deirdre Cilliers; Kim Coleman; Katrina Tatton-Brown; Karen Barker; Brigitte Bernhard; John Burn; Susan Huson; Dragana Josifova; Didier Lacombe; Mohsin Malik; Sahar Mansour; Evan Reid; Valerie Cormier-Daire; Trevor Cole; Nazneen Rahman
Journal:  Nat Genet       Date:  2007-07-15       Impact factor: 38.330

  9 in total
  4 in total

1.  Role of CT Imaging with Volume Reconstruction in Hemi Facial Hypertrophy: A Pediatric Case Report.

Authors:  Gurubharath I; Lakshmi Sudha Prasanna Karanam; Ramesh P
Journal:  J Clin Diagn Res       Date:  2014-06-20

2.  Hemifacial lipomatosis, a possible subtype of partial hemifacial hyperplasia: CT and MR imaging findings.

Authors:  P Bou-Haidar; P Taub; P Som
Journal:  AJNR Am J Neuroradiol       Date:  2009-11-19       Impact factor: 3.825

3.  Hemifacial Hyperplasia.

Authors:  Loutfi Salti; Michael Rasse; Khaled Al-Ouf
Journal:  Contemp Clin Dent       Date:  2017 Apr-Jun

4.  Screening Procedure for Hemihypertrophy: Preliminary Results of International Multicenter Prospective Study.

Authors:  Michael Vaiman; Phillip Shilco; Yulia Roitblat; Nicolas Padilla-Raygoza; Aidan Leit; Aaron Kavin; Edan Schonberger; Liliia Nehuliaieva; Noa Buchris; Michael Shterenshis
Journal:  Cent Asian J Glob Health       Date:  2019-03-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.